Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Verrica Pharmaceuticals stock has a target of 17, which predicts a 209.09% increase from the current stock price of 5.5.

Price Target: $17 (+209.09%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$17	$17	$17
Change	+209.09%	+209.09%	+209.09%	+209.09%

* Price targets were last updated on Dec 18, 2025.

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kemp Dolliver Brookline Capital	Brookline Capital	Hold → Strong Buy Upgrades $17	Hold → Strong Buy	Upgrades	$17	+209.09%	Dec 18, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 14, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 9, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 8, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

25.63M

Decreased by -27.95%

from 35.58M

Revenue Next Year

49.25M

Increased by 92.12%

from 25.63M

EPS This Year

-1.21

from -1.68

EPS Next Year

-0.19

from -1.21

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	12.00M	9.03M	5.12M	7.57M	35.58M	25.63M	49.25M
Revenue Growth	-	-24.73%	-43.27%	47.66%	370.22%	-27.95%	92.12%
EPS	-13.00	-7.17	-14.78	-14.78	-1.68	-1.21	-0.19
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	31.5M	69.5M
Avg	25.6M	49.2M
Low	18.1M	20.8M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	-11.5%	171.2%
Avg	-28.0%	92.1%
Low	-49.2%	-18.9%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-1.04	-0.20
Avg	-1.21	-0.19
Low	-1.50	-0.19

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.